Marksans Pharma Ltd share price logo

Marksans Pharma Share Price

NSE: MARKSANS

BSE: 524404

Small Cap

Healthcare Sector

₹181.70

+3.12

(+1.75%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Marksans Pharma Stock Performance

as on February 17, 2026 at 5:27 pm IST

  • Day's Low

    Day's High

    ₹178.00
    ₹181.90
    downward going graph

    2.04%

    Downside

    0.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹156.00
    ₹270.70
    downward going graph

    14.14%

    Downside

    48.98%

    Upside

    downward going graph

Marksans Pharma share price movements today

Previous Close
₹178.58
Open
₹181.70
Volume
1.37L
Upper Circuit
₹214.29
Lower Circuit
₹142.87
Day's Low - High
₹178.00 - ₹181.90
52 Week Low - High
₹156.00 - ₹270.70

Marksans Pharma Historical Returns

1 Month Return
+ 3.17 %
3 Month Return
-8.47 %
1 Year Return
-25.46 %
3 Year Return
+ 159.56 %
5 Year Return
+ 222.06 %

Marksans Pharma Fundamentals

as on February 17, 2026 at 11:57 am IST

Market Cap

₹8,092.60 Cr

Return on Equity (ROE)

14.45

PE Ratio (TTM)

22.43

Return on capital employed (ROCE)

18.55

Industry PE ratio

41.05

Beta (LTM)

1.34

P/B Ratio

7.28

Dividend Yield

0.36

PEG Ratio

-131.97

Quarterly Earnings Growth YOY

8.2

EPS (TTM)

8.44

Sector

Pharmaceuticals

Book Value

54.44

Technical Analysis

Bullish

View Technical Analysis

Marksans Pharma Stock Valuation

as on February 17, 2026 at 11:57 am IST

Marksans Pharma in the last 5 years

  • Overview

  • Trends

Lowest (4.67x)

April 1, 2020

Today (22.43x)

February 16, 2026

Industry (41.05x)

February 16, 2026

Highest (46.60x)

January 24, 2018

LowHigh

Today’s Price to Earnings Ratio: 22.43x

Marksans Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Marksans Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Marksans Pharma Ltd image
Marksans Pharma Ltd
BUY8,092.6044.41%0.563822,622
Quest Laboratories Ltd image
Quest Laboratories Ltd
NA200.91-3.36%0.0013103
Gland Pharma Ltd image
Gland Pharma Ltd
BUY29,791.26-4.67%0.536985,616
Makers Laboratories Ltd image
Makers Laboratories Ltd
NA79.92-9.8%0.7110120
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA22,260.0028.23%0.001151,716
See all

Analyst Recommendation on Marksans Pharma Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Marksans Pharma. Average target price of ₹225

Source: S&P Global Market Intelligence

Marksans Pharma Share Price Target

Get share price movements and forecasts by analysts on Marksans Pharma.

What analysts predicted

25.99%UPSIDE

Target Price

₹225

Current Price

₹181.7

Analyzed by

2 Analysts

High

₹240

Target

₹225.00

Low

₹210

Marksans Pharma target price ₹225, a slight upside of 25.99% compared to current price of ₹181.7. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Marksans Pharma Stock’s Investor Sentiment and Interest

Investment in Marksans Pharma Ltd Shares on INDmoney has grown by 39.53% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:39.53% versus previous 30 day period

Search interest for Marksans Pharma Ltd Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

Marksans Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
485.98
500.03
531.24
586.13
560.01
590.62
641.92
681.85
708.46
619.99
720.41
754.43
Other Income
11.01
10.1
19
4.8
16.53
14.95
-0.07
27.85
15.34
5.64
21.57
20.14
Total Income
496.99
510.13
550.23
590.93
576.54
605.57
641.85
709.7
723.8
625.63
741.98
774.57
Expenses
376.43
398.07
417.29
453.11
450.37
462.18
495.11
543.08
581.52
519.87
575.92
593.69
Operating Profit
109.55
101.96
113.95
133.02
109.64
128.44
146.81
138.77
126.94
100.12
144.49
160.74
Operating Profit Margin %
22.54%
20.39%
21.45%
22.69%
19.58%
21.75%
22.87%
20.35%
17.92%
16.15%
20.06%
21.31%
Profit Before Interest, Tax and Depreciation
120.56
112.06
132.95
137.82
126.17
143.39
146.74
166.61
142.27
105.76
166.07
180.89
Interest
2.44
1.58
1.63
3.16
4.84
2.92
2.63
2.67
3.44
6.07
5.82
5.94
Depreciation
13.94
13.66
17.55
22
21.06
20.44
19.51
20.69
22.74
23.1
26.92
24.33
Profit Before Tax
104.18
96.82
113.77
112.66
100.27
120.03
124.6
143.25
116.09
76.59
133.33
150.62
Tax Paid
21.47
26.38
29.91
29.7
22.63
30.95
26.84
38.19
25.37
18.4
34.2
36.94
Profit After Tax
82.71
70.44
83.85
82.97
77.64
89.07
97.76
105.07
90.73
58.2
99.14
113.69
Total Net profit including share of profit / Loss from associate company
82.71
70.44
83.85
82.97
77.64
89.07
97.76
105.07
90.73
58.2
99.14
113.69
EPS
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
2.17
2.5
Actual EPS
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
2.17
2.5
Adjusted EPS
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
2.17
2.5
Diluted EPS
1.97
1.52
1.84
1.84
1.73
1.96
2.13
2.31
2
1.29
2.17
2.5

Marksans Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
767.16
912.69
1,000.07
1,134.21
1,376.18
1,490.84
1,852.14
2,177.41
2,622.85
Other Income
7.02
8.47
4.62
0.33
6.69
41.85
59.31
50.42
66.33
Total Income
774.18
921.17
1,004.69
1,134.54
1,382.88
1,532.69
1,911.45
2,227.83
2,689.17
Expenses
722.42
834.31
867.92
941.96
1,036.58
1,231.96
1,512.82
1,718.83
2,090.16
Operating Profit
44.74
78.38
132.15
192.25
339.6
258.88
339.32
458.58
532.69
Operating Profit Margin %
5.83%
8.59%
13.21%
16.95%
24.68%
17.36%
18.32%
21.06%
20.31%
Profit Before Interest, Tax and Depreciation
51.77
86.86
136.77
192.58
346.3
300.73
398.63
509
599.01
Interest
6.78
10.22
9.66
8.75
7.99
8.45
9.13
11.2
11.66
Depreciation
30.09
26.84
22.8
26.66
36.15
44.78
51.85
74.27
83.39
Profit Before Tax
14.9
49.8
104.31
157.17
302.16
247.5
337.65
423.53
503.96
Tax Paid
3.56
14
23.88
36.42
63.62
60.7
72.33
108.63
121.35
Profit After Tax
11.34
35.8
80.44
120.75
238.54
186.81
265.32
314.9
382.62
Total Net profit including share of profit / Loss from associate company
11.34
35.8
80.44
120.75
238.54
186.81
265.32
314.9
382.62
EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4
Actual EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4
Adjusted EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4
Diluted EPS
0.22
0.8
1.87
2.86
5.76
4.51
6.41
6.92
8.4

Marksans Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
30.8
14.06
50.09
27.4
233.33
178.59
99.26
237.41
230.41
206.66
Cash Flow from Investing Activities
-123.01
-20.72
-38.81
-13.48
-59.59
-44.85
-84.4
-259.2
-140.84
-49
Cash Flow from Financing Activities
-57.75
-3.48
3.39
-20.78
-113.56
-15.28
79.52
197.83
-68.73
-65.16
Net Cash Flow
-149.96
-10.14
14.67
-6.86
60.19
118.46
94.38
176.03
20.84
92.51

Marksans Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
43.85%
43.85%
43.85%
43.85%
43.85%
43.87%
43.87%
43.87%
43.87%
43.87%
43.87%
43.87%
DII
1.46%
3.65%
3.15%
3.82%
5.17%
3.75%
4.1%
4.3%
4.56%
5.5%
5.28%
5.91%
FII
10.88%
10.88%
10.88%
10.88%
15.57%
18.6%
21.31%
21.96%
22.2%
19.88%
16.92%
8.12%
Public
39.58%
37.59%
37.06%
35.83%
35.4%
33.78%
30.71%
29.87%
29.37%
30.75%
33.93%
42.09%
Total Outstanding Shares
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
45,31,63,746
Total Shareholders
1,98,382
1,88,447
2,07,937
2,37,377
2,54,699
2,35,500
2,48,845
2,59,813
2,57,273
2,56,221
2,65,788
2,55,153

Mutual Funds that own Marksans Pharma Stock

Check out the Mutual Funds with significant holdings in Marksans Pharma.

Marksans Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Marksans Pharma.

  • Marksans Pharma Ltd Earnings Results

    Marksans Pharma Ltd’s net profit jumped 8.26% since last year same period to ₹113.20Cr in the Q3 2025-2026. On a quarterly growth basis, Marksans Pharma Ltd has generated 15.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Marksans Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Marksans Pharma Ltd has declared dividend of ₹0.80 per share on 19 May 2025 - translating a dividend yield of 0.77%.

    Read More about Dividends

Indices Featuring Marksans Pharma Stock

Check stock indices that include Marksans Pharma.

BSE Healthcare

₹43,187.49

0.48 (▲207.53%)

Insights on Marksans Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 33.93% to 42.09% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 625.63 Cr → 774.57 Cr (in ₹), with an average increase of 9.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 58.32 Cr → 113.2 Cr (in ₹), with an average increase of 26.9% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.92% to 4.41% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 186.1% return, outperforming this stock by 26.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 43.87% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 38.5% return, outperforming this stock by 63.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.30% to 8.12% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MARKSANS stock has moved down by -4.5%

About Marksans Pharma Ltd

Marksans Pharma Limited is a public limited company that specializes in research, manufacture, marketing and sale of pharmaceutical formulations. Established in April 1982, the Company has its research and development centers located in Verna Goa and Navi Mumbai. On 30th March 2015, they issued and allotted 24006494 equity shares of ₹1 each to qualified institutional buyers for ₹54.67 per share under QIP. On 7th February 2015, the Company decided to redeem 1350000 cumulative redeemable preference shares of face value ₹100 each out of profits in tranches before due date of redemption, which was decided to be 27th March 2018. 50000 Bonds of USD 1000 value each were issued during the financial year 2015, out of which 49939 Bonds were bought and extinguished by the Company. 150000 preference shares of ₹100 each were redeemed at par in 2017 and the issued, subscribed and paidup preference share capital was reduced to 1100000 of ₹100 each. Marksans Pharma Limited is a long-standing public limited company offering research, manufacture, marketing and sale of pharmaceutical formulations.

Revenue: ₹754.43Cr as on December 2025 (Q3 FY26)
Net Profit: ₹113.69Cr as on December 2025 (Q3 FY26)
Listing date: 21 Jan, 2002
Chairperson Name: Mark Saldanha
OrganisationMarksans Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMark Saldanha
E-voting on sharesClick here to vote

FAQs

What is Marksans Pharma share price today?

Marksans Pharma share price today stands at ₹181.7 as on . Marksans Pharma share today touched a day high of ₹181.9 and a low of ₹178.

What is the 52 week high and 52 week low range for Marksans Pharma share?

Marksans Pharma touched a 52 week high of ₹270.7 and a 52 week low of ₹156. Marksans Pharma share price today i.e. is trending at ₹181.7, which is -32.88% down from its 52 week high and 16.47% up from its 52 week low.

What is Marksans Pharma's market capitalisation today?

Marksans Pharma market capitalisation is ₹8,092.60 Cr as on .

How to buy Marksans Pharma shares?

To buy Marksans Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MARKSANS or Marksans Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Marksans Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Marksans Pharma trading volume today?

Marksans Pharma trading volume is 1.37L as on . This means that 1.37L shares of Marksans Pharma were bought and sold on the stock market during today's trading session.